Profile of immunologic recovery in HIV-infected Ugandan adults after antiretroviral therapy

被引:12
作者
Baker, Chris A. R.
Emenyonu, Nneka
Ssewanyana, Isaac
Jones, Norman G.
Elrefaei, Mohamed
Nghania, Frehd
Nakiwala, Justine
Andia, Irene
Clark, Richard
Martin, Jeffrey
Bangsberg, David R.
Cao, Huyen
机构
[1] Calif Dept Hlth Serv, VRDL, Richmond, CA 94804 USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Joint Clin Res Ctr, Kampala, Uganda
关键词
D O I
10.1089/aid.2006.0309
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HIV infection is characterized by a decrease in total CD4 cell count, rising viral load, as well as an increase in immune activation levels. Increased activation can lead to an increase in apoptosis and contribute to CD4 depletion. We evaluated the clinical and immunologic responses of 23 HIV-positive Ugandan volunteers following initiation of antiretroviral therapy (ART). All volunteers achieved and maintained complete viral suppression within the first 3 months of therapy (p > 0.05). CD4(+) and CD8(+) T cell activation also decreased significantly, although it never reached the level of HIV negative Ugandan volunteers. Viral suppression and CD4 cell recovery were also associated with an improved profile in CD8(+) T cell functional markers, but had no effect on HIV-specific proliferation. We conclude that ART in a cohort of therapy-naive Ugandans with AIDS partially restores but does not fully reverse the immune dysfunction observed in chronic HIV infection.
引用
收藏
页码:900 / 905
页数:6
相关论文
共 62 条
[31]   Changes in levels of immune activation and reconstitution markers among HIV-1-infected Africans receiving antiretroviral therapy [J].
Koblavi-Dème, S ;
Maran, M ;
Kabran, N ;
Borget, MY ;
Kalou, M ;
Kestens, L ;
Maurice, C ;
Sassan-Morokro, M ;
Ekpini, ER ;
Roels, TH ;
Chorba, T ;
Nkengasong, JN .
AIDS, 2003, 17 :S17-S22
[32]   Evidence of immune reconstitution in antiretroviral drug-experienced patients with advanced HIV disease [J].
Landay, AL ;
Bettendorf, D ;
Chan, E ;
Spritzler, J ;
Schmitz, JL ;
Bucy, RP ;
Gonzalez, CJ ;
Schnizlein-Bick, CT ;
Evans, T ;
Squires, KE ;
Phair, JP .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2002, 18 (02) :95-102
[33]   Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin-V and 7-AAD cytofluorometric staining methods [J].
Lecoeur, H ;
Ledru, E ;
Prévost, MC ;
Gougeon, ML .
JOURNAL OF IMMUNOLOGICAL METHODS, 1997, 209 (02) :111-123
[34]   Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: Results of AIDS clinical trials group protocol 315 [J].
Lederman, MM ;
Connick, E ;
Landay, A ;
Kuritzkes, DR ;
Spritzler, J ;
St Clair, M ;
Kotzin, BL ;
Fox, L ;
Chiozzi, H ;
Leonard, JM ;
Rousseau, F ;
Wade, M ;
Roe, JD ;
Martinez, A ;
Kessler, H .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (01) :70-79
[35]  
MacPherson PA, 2001, J ACQ IMMUN DEF SYND, V28, P454, DOI 10.1097/00042560-200112150-00008
[36]   Use of overlapping peptide mixtures as antigens for cytokine flow cytometry [J].
Maecker, HT ;
Dunn, HS ;
Suni, MA ;
Khatamzas, E ;
Pitcher, CJ ;
Bunde, T ;
Persaud, N ;
Trigona, W ;
Fu, TM ;
Sinclair, E ;
Bredt, BM ;
McCune, JM ;
Maino, VC ;
Kern, F ;
Picker, LJ .
JOURNAL OF IMMUNOLOGICAL METHODS, 2001, 255 (1-2) :27-40
[37]   The dynamics of CD4+ T-cell depletion in HIV disease [J].
McCune, JM .
NATURE, 2001, 410 (6831) :974-979
[38]  
Messele T, 1999, CLIN EXP IMMUNOL, V115, P443
[39]   PROGRAMMED DEATH OF T-CELLS IN HIV-1 INFECTION [J].
MEYAARD, L ;
OTTO, SA ;
JONKER, RR ;
MIJNSTER, MJ ;
KEET, RPM ;
MIEDEMA, F .
SCIENCE, 1992, 257 (5067) :217-219
[40]  
Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845